Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gutman

Showing results (251-260 of 279) with videos related to

Pageof 28
Sort By:
Oncogene|December 5, 1996
Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potentialS Huang, M Luca, M Gutman, et al.
Cancer|April 3, 2001
Multiple primary malignancies in association with soft tissue sarcomasO Merimsky, Y Kollender, J Issakov, et al.
Oncology Reports|June 22, 1999
Adriamycin-ifosfamide induction chemotherapy for extremity soft tissue sarcoma: comparison of two non-randomized protocolsO Merimsky, I Meller, J Issakov, et al.
Journal of Surgical Oncology|April 2, 1999
Multifocal soft tissue sarcoma: limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalanD Lev-Chelouche, S Abu-Abeid, Y Kollander, et al.
Melanoma Research|June 1, 1995
Treatment of nude mice with 4-amidinoindan -1- one2 '- amidinohydrazone, a new S-adenosylmethionine decarboxylase inhibitor, delays growth and inhibits metastasis of human melanoma cellsM Gutman, P J Beltran, D Fan, et al.
Harefuah|August 24, 2000
[Retroperitoneal sarcoma. Treatment of 51 patients]D Lev-Chelouche, S Abu-Abeid, M Gutman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 20, 1999
Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcomaD Lev-Chelouche, S Abu-Abeid, O Merimsky, et al.
The Journal of Experimental Medicine|April 1, 1995
Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cellsK Xie, S Huang, Z Dong, et al.
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1992
Malignant melanoma of the mucous membranesM Gutman, M Inbar, S Chaitchik, et al.
Pageof 28

Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Oncogene|December 5, 1996
Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potentialS Huang, M Luca, M Gutman, et al.
Cancer|April 3, 2001
Multiple primary malignancies in association with soft tissue sarcomasO Merimsky, Y Kollender, J Issakov, et al.
Oncology Reports|June 22, 1999
Adriamycin-ifosfamide induction chemotherapy for extremity soft tissue sarcoma: comparison of two non-randomized protocolsO Merimsky, I Meller, J Issakov, et al.
Journal of Surgical Oncology|April 2, 1999
Multifocal soft tissue sarcoma: limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalanD Lev-Chelouche, S Abu-Abeid, Y Kollander, et al.
Melanoma Research|June 1, 1995
Treatment of nude mice with 4-amidinoindan -1- one2 '- amidinohydrazone, a new S-adenosylmethionine decarboxylase inhibitor, delays growth and inhibits metastasis of human melanoma cellsM Gutman, P J Beltran, D Fan, et al.
Harefuah|August 24, 2000
[Retroperitoneal sarcoma. Treatment of 51 patients]D Lev-Chelouche, S Abu-Abeid, M Gutman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 20, 1999
Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcomaD Lev-Chelouche, S Abu-Abeid, O Merimsky, et al.
The Journal of Experimental Medicine|April 1, 1995
Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cellsK Xie, S Huang, Z Dong, et al.
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1992
Malignant melanoma of the mucous membranesM Gutman, M Inbar, S Chaitchik, et al.
Pageof 28